首页 | 本学科首页   官方微博 | 高级检索  
     


Wilms’ Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short‐lived WT1‐specific immune responses
Authors:Adam Ivey  Charles Craddock  Frederick Chen  Andras Virchis  Panagiotis Kottaridis  David Grimwade  Asim Khwaja  Hans Stauss  Emma C. Morris
Affiliation:1. Division of Genetics and Molecular Medicine, Department of Medical and Molecular Genetics, Kings College London, , London, UK;2. Centre for Clinical Haematology, Queen Elizabeth Hospital NHS Foundation Trust, , Birmingham, UK;3. Department of Haematology, Barnet and Chase Farm Hospital, , London, UK;4. Department of Haematology, Royal Free London Hospital NHS Foundation Trust, , London, UK;5. Department of Haematology, University College London Hospital NHS Foundation Trust, , London, UK;6. UCL Division of Infection and Immunity, Department of Immunology, University College London, , London, UK
Abstract:
Keywords:acute myeloid leukaemia  immunotherapy  tumour antigens  trials
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号